| 摘要 |
<p>The present invention relates to a method for predicting the responsiveness of a patient to a treatment with an IL-6 antagonist, said method comprising measuring in a blood sample obtained from said patient the level of at least one subpopulation of blood monocytes selected from the group consisting of classical monocytes, intermediate monocytes and non classical patrolling monocytes.</p> |
